Survival rate of cardiac arrest in Australia is approx 10%, but with CPR and an AED, it can jump to 60–70%! Tassie has a ⬆️incidence of cardiac arrests, but ⬇️rate of bystander intervention. To save a life: ✅ Recognise a cardiac arrest ✅ Call 000 ✅ Start CPR ✅ Find an AED - it's simple to use!

New Year, new skills? Do you know how to perform CPR or use an AED? If not, why not make it a goal for 2026! Our Cardiovascular Research Flagship team have re-released Shock Verdict – this powerful yet fun video featuring the cast of ABC’s Rake ➡ www.utas.edu.au/.../cardiovascular.../shock-verdict

☀️ Have you checked out the Summer edition of our quarterly Bulletin yet? ➡️ lnkd.in/gSaFvuZr We’ve packed it with highlights from some of our favourite events and exciting projects we're working on!

📢 Our final MS Research Flagship newsletter for 2025 is here! It’s packed with insights and updates you won’t want to miss: ✅ Cost of MS in Australia ✅ Global collaborations in action ✅ Digital innovation spotlight ✅ New research on sleep and MS. 👉 Read it in full here: bit.ly/4a70zTx

We are enormously proud of our very own Professor Bruce Taylor who received the 2025 MS Research Award at MS Australia's Progress in #MultipleSclerosis Research Conference last week in Brissy. MS Australia: "His work has shaped much of what we know about MS today." #MSresearchconf2025 📷MS Australia

Thanks to our MS Flagship's Mustafa Kamal, Bennet McComish (@drmcstrange.bsky.social) Laura Laslett (@lauralaslettphd.bsky.social) + Tadeg Amale for sharing their research posters on gender-based income gaps for people with MS, sleep disorders in MS and more at last week's #MSResearchConf2025 👏

Presenting their research posters at MS Australia's #MSResearchConf2025 were our MS Flagship's Mohammed Obsa, Bec Banham, Glen Henson + Valery Fuh-Ngwa. Their projects covered everything from evaluating MS treatment effectiveness to NDIS participation influences for people with #multiplesclerosis

👏 Congratulations to Dr Holly Emery @utas.edu.au for her standout presentation at MS Australia’s #MSResearchConf2025 in Brisbane! She shared insights from her important research into how changes in psychosocial factors shape self-concept in people with #MultipleSclerosis

Dr Alice Saul captivated a full room of MS community members, plus many tuning in via livestream, at MS Australia’s #MSResearchConf2025, sharing her work on identifying pain type profiles in people with #MultipleSclerosis.

What an incredible showing from @utas.edu.au Menzies and Tassie-based MS community members at MS Australia’s #MSResearchConf2025 in Brisbane! With the theme Causes | Care | Cures it was an inspiring few days of sharing #MultipleSclerosis research, knowledge, sparking ideas and building connections 🧠

Dr Nicholas Blackburn (@nickomatics.bsky.social) of our MS Research Flagship, and session chair at #MSResearchConf2025, expertly sets the scene for a deep dive into genetics, neurobiology and the disease mechanisms of #multiplesclerosis on day two of MS Australia's conference in Brisbane.

How does sleep quality affect work productivity for Australians living with #MultipleSclerosis? Professor van der Mei from our MS Research Flagship shares key findings from her research, including the potential benefit of developing a sleep intervention, at #MSResearchConf2025

Congrats to our PhD student Panteha Khaledi on her fantastic presentation at MS Australia’s #MSResearchConf2025! Her work, in collaboration with QIMR Berghofer, explores T cell immunity and Epstein-Barr virus in #MultipleSclerosis, and reveals exciting progress in understanding this complex disease.

"Multiple sclerosis is costing Australians more than $3b a year and number of people with MS up 77% since 2010" - Professor Bruce Taylor presents about the Health Economic Impact of MS in Australia report at MS Australia's Progress in MS Research Conference #MSResearchConf2025 #MS #multiplesclerosis

👏 Huge congratulations to Dr Yi Chao Foong @ycfoong.bsky.social from our MS Research Flagship! On the final day of #PACTRIMS in Osaka 🇯🇵 he shared his important work on treating older people with #multiplesclerosis based on real-world data from the MSBase registry 🌏 #MSResearch #PACTRIMS2025

Professor Bruce Taylor from our #MS Research Flagship is in Osaka 🇯🇵 for the 17th #PACTRIMS Congress! He shared results from TAURUS 2, a phase II randomised controlled clinical trial exploring magnetic brain stimulation (rTMS) as a treatment for #MultipleSclerosis.

We wish to congratulate Michael Whittle, a valued member of our Cardiovascular Research Flagship’s Lived Experience Advisory Group, who was announced last night as the Volunteer of the Year at the National Stroke Awards 2025.

[email protected], from our Cardiovascular Research Flagship, recently represented our team at the Artery Society Conference in Valencia, Spain. She presented her team’s important work on vascular ageing in youth, vital work for understanding and preventing cardiovascular disease late life

Tomorrow is Ride2Work day! Our research shows that a lack of physical activity is a major risk factor for many chronic conditions. But small lifestyle changes like cycling to work is a great way to incorporate physical activity into your day! We are proud to pledge our support to Ride2Work Day 2025

Isis Loos, a PhD candidate with our Cardiovascular Research Flagship, whose research is part of Communities for Walkability project, recently spoke to the U3A, Rosny, sharing data insights into how walking more can shape healthier communities. Sharing our research is an important part of what we do!

🌟 𝐌𝐞𝐞𝐭 𝐨𝐮𝐫 𝐄𝐌𝐂𝐑 𝐌𝐢𝐧𝐢 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦 𝐂𝐚𝐫𝐞𝐞𝐫 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐏𝐚𝐧𝐞𝐥𝐥𝐢𝐬𝐭: 𝐀⁄𝐏𝐫𝐨𝐟 𝐏𝐡𝐢𝐥𝐥𝐢𝐩𝐩𝐚 𝐓𝐚𝐛𝐞𝐫𝐥𝐚𝐲 🌟 We’re thrilled to introduce @piptaberlay.bsky.social, Principal Research Fellow and Cancer and Genomics Theme Lead at @menzies-research.bsky.social, @utas.edu.au, and incoming Chair of @aepia.bsky.social

Congrats to Dr Serah Kalpakavadi on delivering her final PhD seminar, under the supervision of Prof Seana Gall in the Cardiovascular Research Flagship! Her research, “Better prediction of stroke through identifying preceding health service encounters,” is part ofan NHMRC-funded grant, STOPstroke.

By bringing together diverse voices, we’re working to ensure scientifically robust AND socially relevant research. These conversations are central to our co-design approach, and places lived experience at the heart of our strategy #CardiovascularResearch #CoDesign #LivedExperience #Researchworkshop

This workshop was 3rd in a series of engagement activities designed to ensure our research is deeply connected to the values, needs, and aspirations of the Tasmanian community—particularly in relation to cardiovascular disease #CoDesign #LivedExperience #Researchworkshop

Our Cardiovascular Research Flagship team recently met with the Lived Experience Advisory Group, plus policy and practice professionals from across Tas for a strategic workshop focused on confirming research priorities. #CardiovascularResearchResearch #CoDesign #LivedExperience #Researchworkshop

It’s International Day of Older Persons! 🌏👵👴 As our population ages, supporting healthy ageing is vital. Our #MS Research Flagship's free online course helps people with #MultipleSclerosis age well & plan ahead. 👉 Enrol today: ms.mooc.utas.edu.au/i/ageingf #HealthyAgeing #MSResearch #onlinelearning

🟣 It’s the final day of #PainAwarenessMonth, so what better time to spotlight the invisible burden many people with #MultipleSclerosis carry. A new study from our #MSResearch Flagship researchers found that 53% of over 1600 participants experience regular pain. 20% reported 5–10 different types.

Congratulations to Dr Yuan Zhou of our #MultipleSclerosis Flagship who expertly presented on his multi-omics approach to investigating the Epstein-Barr virus EBV-MS connection to the world stage at the International Multiple Sclerosis Genetics Consortium (IMSGC) meeting in Barcelona, Spain. #EBV #MS

👏Proud to see our MS Research Flagship researchers contribute to the EBV-MS consortium meeting at #ECTRIMS2025 in Barcelona—sharing ideas, bringing the Australian perspective, building global connections & advancing research into EBV’s role in MS. #MSResearch #EBV #MSAustralia #GlobalCollaboration

Can high-efficacy treatments improve outcomes for people diagnosed with #MultipleSclerosis later in life? Dr Yi Chao Foong @ycfoong.bsky.social from our #MSResearch Flagship explores this in his poster at #ECTRIMS2025 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025

What impact do #MultipleSclerosis treatments, particularly B cell therapies, have on Epstein-Barr virus activity? Our MS Research Flagship's Dr Chhavi Asthana presents her poster investigating that @ #ECTRIMS2025 🔗msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MSResearch

Our MS Research Flagship's Panteha Khaledi presents her poster at #ECTRIMS2025! Her study explores how the immune system’s T cells respond to Epstein-Barr virus (EBV) in people with #MultipleSclerosis 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MSResearch

Our MS Research Flagship's Himanshu Saraswat is at #ECTRIMS2025! His study investigated whether rare genetic variants in families with multiple MS cases could help explain MS risk. More 👇 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

Dr Xin Lin from our MS Research Flagship is at #ECTRIMS2025! His poster reveals how genetic structural variation in complement component 4 affects risk of MS onset and disability progression. 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

Our MS Research Flagship's Prof Bruce Taylor is at #ECTRIMS2025! His poster explores how genetic oxidative stress and low Mediterranean diet intake combine to influence MS onset risk. More 👇 🔗 msresearchflagship.org.au/researchers/ms-research-flagship-at-ectrims-2025 #MultipleSclerosis #MSResearch

In CDAH 3, over 3,100 participants were involved in clinical trials or via questionnaires during 2014-2019. Findings over the 40 years have helped to shape healthcare guidelines worldwide #Tasmania #CDAH@40 #medicalresearch

Former Menzies Director, Alison Venn, said that CDAH 2, from 2009-2011 about 3000 participants completed a survey, adding more longitudinal data to the study #CDAH@40 #medicalresearch #Tasmania

It was decided that the 1985 data could be used to find evidence of childhood lifestyle on adults. Record funding was granted, and about 80% of the original participants agreed to go through new testing, CDAH 1, where clinics were formed to gather new data. #CDAH@40 #medicalresearch

‪The study began in 1985, when 8,500 children had their health + fitness tested in the Australian School Health and Fitness Survey. Lifestyle, strength, blood pressure and skin fold tests formed some of the data captured said Professor Terry Dwyer, former Menzies Director #CDAH@40 #medicalresearch

Professor Seana Gall has welcomed guests to celebrate 40 years of the Childhood Determinants of Adult Health (CDAH) study - one of the most significant of its kind in Australia #CDAH@40 #medicalresearch #Tasmania

STOPstroke (Synergies TO Prevent stroke) is Australia’s 1st multi-disciplinary research initiative focused on preventing stroke. Recently, we hosted a workshop in Hobart- providing an opportunity for researchers to reflect on the program's impact + discuss the future of stroke prevention research.

🌟Give a little, change a lot. Help our researchers uncover the link between #multiplesclerosis & Epstein-Barr virus in an Australia-wide study.🧬 We need saliva samples from people with & without MS. Click here to check eligibility and participate 👉 redcap.utas.edu.au/surveys/?s=9... #MSresearch #EBV

Big shoutout to all the researchers, clinicians, and lived experience volunteers who made #ANZSOC2025 such a powerful event 💙 The energy, collaboration, and commitment to equity — especially from lived experience voices and local researchers — made this a truly inspiring gathering.

🫁 September is Pulmonary Fibrosis Awareness Month. ~1 million Australians live with this progressive lung disease. It causes lung scarring, breathlessness & chronic cough. Early diagnosis & treatment can slow progression. #PFAM2025 #PulmonaryFibrosis #LungHealth

📣 Would you like to keep up to date with multiple sclerosis research in Tasmania?✉️ Sign up for our MS Research Flagship's e-newsletter, featuring research findings, upcoming events, achievements of our world-class team and how YOU can get involved. Sep issue out now! 👇 createsend.com/t/j-A08713B4...

The #ANZSOC2025 conference brings together clinicians, researchers, policymakers, and people with lived experience to share knowledge and drive change. We’re proud to see members of our Lived Experience Advisory Group attend with Professor Gall to share our Cardiovascular Research Flagship's goals.

With Tasmania facing some of the highest stroke rates nationally, the #ANZSOC2025 conference provides a vital platform to explore the theme “Equity in Stroke” — focusing on improving care and outcomes, particularly in rural and regional communities like Tasmania.

Today, Hobart is proud to host over 330 stroke experts from across Australia and around the world for the Australian and New Zealand Stroke Organisation Conference (ANZSOC) 2025. The event is convened by Professor Seana Gall, lead researcher of our Cardiovascular Research Flagship. #ANZSOC2025

Curious about cardiovascular research? Sign up for our Cardiovascular Research Flagship’s newsletter to get updates on local projects, upcoming events, and the amazing work of our team. Check out the latest edition and subscribe: cardiovascularresearchflagship.createsend1.com/t/j-e-whitkk...

Want to turbo charge your #science career with a #PhD? Find out if people living with #MS are ageing well in this project at @menzies-research.bsky.social www.utas.edu.au/research/deg...